Generation of High Passage and Immortalized Human Microglia Cell Lines
Generation of High Passage and Immortalized Human Microglia Cell Lines
批准号:
8797358
负责人:
CHANGIZ GEULA
金额:
$20.1万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-02-15 至 2015-12-31
关键词:
AdultAgeAlzheimer&aposs DiseaseAmyloidAnti-Inflammatory AgentsAnti-inflammatoryAutopsyBiologyBrainBrain DiseasesCell CountCell LineCellsCerebral cortexChildhoodCommunitiesDiseaseEmbryoEnsureExtracellular MatrixFree RadicalsGenerationsGoalsHealthHumanImmuneIn VitroIndividualInflammatoryInjection of therapeutic agentInvestigationLearningMaintenanceMethodsMicrogliaMolecular ConformationMyelogenousNeuraxisNeurodegenerative DisordersNeuronsNitric OxidePeptidesPhenotypePhysiologicalPreclinical Drug EvaluationPrimatesProcessProductionProliferatingProteinsProteomicsProtocols documentationRNARattusReactive Oxygen SpeciesResearchResearch PersonnelRodentRodent ModelRoleStimulusSynapsesTelomeraseTestingToxic effectTraumaTraumatic Brain InjuryWorkagedaging brainbasechemokinecytokinedrug testinghuman TERT proteinin vivomacrophagemannervous system developmentnonhuman primatereceptor expressionresearch studyresponsespecies differencetooltranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of the proposed research is to generate and extensively characterize high passage and immortalized adult human microglia cell lines. High yield and well characterized adult human microglia cultures from each case will be necessary for mechanistic in vitro studies. Availability of large numbers of cells would also allow initial testing of drugs that can regulate microglial functions and permit isolation of large amounts of RNA and/or protein for transcriptomic or proteomic studies. Microglia have diverse functions in the healthy and diseased brain. A great deal of what has been learned regarding microglia biology is based on in vitro studies the overwhelming majority of which used cells isolated from the rodent brain. However, higher anatomical and functional complexity of the human brain and species differences in microglia response and function make imperative the use of human microglia to ascertain that the results obtained are applicable to man. Furthermore, investigation of microglia functions in the adult brain, in which many inflammatory and anti- inflammatory microglia responses occur, requires use of human microglia from adult brains. Microglia cultured from embryonic human brain show substantial proliferative capacity. However, while methods for isolation of microglia from adult postmortem human brains exist, they allow only use of a limited quantity of microglia isolated and cultured from each case due to low levels of proliferation. In preliminary attempts, we have developed a method that allows culturing microglia from adult postmortem human brains to relatively high passage. Limited preliminary testing indicated that human microglia may maintain their phenotype in high passage cultures. The proposed work will attempt to generate microglia cultures of higher passage and to extensively characterize microglia phenotypes and response to different stimuli at different passages. We will also generate and extensively characterize immortalized human microglia cell lines using a well-established protocol that utilizes human telomerase reverse transcriptase. The specific aims of the proposed work will test the following hypotheses: Aim 1 - Microglia cultured from normal adult human brains of various ages and from brains of individuals with neurodegenerative disorders will proliferate to high passage in vitro. Aim 2 - High passage human microglia will maintain their phenotype, including response to various stimulants. Aim 3 - Human microglia will be successfully immortalized, and immortalized human microglia will maintain their phenotype and response to various stimulants. Successful generation and characterization of high passage and immortalized human microglia cultures will provide the scientific community with new and reliable tools for in vitro mechanistic studies of human microglia function in health from childhood to old age, and in disease, including our own studies of microglia function in Alzheimer's disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease
-
批准号:10901316
-
项目类别:
-
资助金额:$74.79万
-
财政年份:2023
-
负责人:CHANGIZ GEULA
-
依托单位:
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)
-
批准号:10276525
-
项目类别:
-
资助金额:$413.0万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Research Education Component
-
批准号:10469453
-
项目类别:
-
资助金额:$13.57万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Biospecimen/Neuropathology Core
-
批准号:10276530
-
项目类别:
-
资助金额:$56.31万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Biospecimen/Neuropathology Core
-
批准号:10687278
-
项目类别:
-
资助金额:$17.21万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Research Education Component
-
批准号:10264374
-
项目类别:
-
资助金额:$47.42万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Research Education Component
-
批准号:10662493
-
项目类别:
-
资助金额:$12.06万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)
-
批准号:10687271
-
项目类别:
-
资助金额:$127.95万
-
财政年份:2021
-
负责人:CHANGIZ GEULA
-
依托单位:
Cognitive SuperAging: A model to explore resilience and resistance to aging and Alzheimers disease
-
批准号:10359727
-
项目类别:
-
资助金额:$75.18万
-
财政年份:2020
-
负责人:CHANGIZ GEULA
-
依托单位:
Characterized Adult Primary Human Microglia Cells for Research
-
批准号:10004183
-
项目类别:
-
资助金额:$26.61万
-
财政年份:2018
-
负责人:CHANGIZ GEULA
-
依托单位:
Characterized Adult Primary Human Microglia Cells for Research
-
批准号:9788539
-
项目类别:
-
资助金额:$26.3万
-
财政年份:2018
-
负责人:CHANGIZ GEULA
-
依托单位:
Characterized Adult Primary Human Microglia Cells for Research
-
批准号:10248370
-
项目类别:
-
资助金额:$26.01万
-
财政年份:2018
-
负责人:CHANGIZ GEULA
-
依托单位:
7th Intern Conf on AD and Related Disorders in the Middle East
-
批准号:9261277
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2016
-
负责人:CHANGIZ GEULA
-
依托单位:
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates
-
批准号:9918541
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype
-
批准号:8896086
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates
-
批准号:9056631
-
项目类别:
-
资助金额:$46.73万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype
-
批准号:9923902
-
项目类别:
-
资助金额:$68.56万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype
-
批准号:10600105
-
项目类别:
-
资助金额:$66.79万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
Concordance of TDP-43 Inclusions with Cortical Atrophy and Clinical Phenotype
-
批准号:9326361
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
Generation of High Passage and Immortalized Human Microglia Cell Lines
-
批准号:8707277
-
项目类别:
-
资助金额:$25.32万
-
财政年份:2014
-
负责人:CHANGIZ GEULA
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: